Integrative genomic analyses on GL12: Mechanism of Hedgehog priming through basal GL12 expression, and interaction map of stem cell signaling network with P53

International Journal of Oncology

Volumn 33, Issue 4, 2008, Pages 881-886

  Katoh, Yuriko ^a   Katoh, Masaru ^b  

^a M&M Medical BioInformatics   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

AKT; EGFR; GSK 3 ; Hedgehog; HIPK2; MDM2; MDM4; MDMX; Notch; P53; P63; P73; Protein kinase A; Smoothened; WNT

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MESSENGER RNA; NOTCH1 RECEPTOR; PROTEIN P53; PROTEIN P63; PROTEIN P73; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5; TRANSFORMING GROWTH FACTOR BETA;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BINDING SITE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE GENE MAPPING; EXON; FETUS HEART; FETUS LUNG; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC CODE; GENETIC CONSERVATION; GENOME ANALYSIS; HUMAN; LIVER REGENERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; RAT; REGULATORY MECHANISM; REPRESSOR GENE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STEM CELL; STOMACH CANCER; TANDEM REPEAT; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR CELL LINE; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENOMICS; HEDGEHOG PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RATS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 54049156465     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000076     Document Type: Article

References (62)

1. Marigo V, Roberts DJ, Lee SM, et al: Cloning, expression, and chromosomal location of SHH and IHH. Genomics 28: 44-51, 1995.
2. Beachy PA, Karhadkar SS and Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature 432: 324-331, 2004.
3. Van den Brink GR, Bleuming SA, Hardwick JC, et al: Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet 36: 277-282, 2004.
4. Hooper JF and Scott MP: Communicating with Hedgehogs. Nature Rev Mol Cell Biol 6: 306-317, 2005.
5. Katoh Y and Katoh M: Hedgehog signaling pathway and gastrointestinal stem cell signaling network. Int J Mol Med 18: 1019-1023, 2006.
6. Johnson RL, Rothman AL, Xie J, et al: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668-1671, 1996.
7. Stone DM, Hynes M, Annanini M, et al: The tumour-suppressor gene Patched encodes a candidate receptor for Sonic hedgehog. Nature 384: 129-134, 1996.
8. Dahmane N, Lee J, Robins P, Heller P and Ruiz i Altaba A: Activation of the transcription factor G1i1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389: 876-881, 1997.
9. Watkins DN, Berman DM, Burkholder SG, et al: Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422: 313-317, 2003.
10. Berman DM, Karhadkar SS, Maitra A, et al: Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425: 846-851, 2003.
11. Thayer SP, Di Magliano MP, Heiser PW, et al: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856, 2003.
12. Karhadkar SS, Bova GS, Abdallah N, et al: Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431: 707-712, 2004.
13. Katoh Y and Katoh M: Hedgehog signaling in gastric cancer. Cancer Biol Ther 4: 1050-1054, 2005.
14. Lindemann RK: Stroma-initiated Hedgehog signaling takes center stage in B-cell lymphoma. Cancer Res 68: 961-964, 2008.
15. Chamoun Z, Mann RK, Nellen D, et al: Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science 293: 2080-2084, 2001.
16. Breitling R: Greased hedgehogs: new links between hedgehog signaling and cholesterol metabolism. BioEssays 29: 1095-1094, 2007.
17. Burke R, Nellen D, Bellotto M, et al: Dispatched, a novel sterolsensing domain protein dedicated to the release of cholesterol-modified hedgehog from signaling cells. Cell 99: 803-815, 1999.
18. Tenzen T, Allen BL, Cole F, et al: The cell surface membrane proteins Cdo and Boc are components and targets of the Hedgehog signaling pathway and feedback network in mice. Dev Cell 10: 647-656, 2006.
19. Allen BL, Tenzen T and McMahon AP: The Hedgehog-binding proteins GasI and Cdo cooperate to positively regulate Shh signaling during mouse development. Genes Dev 21: 1244-1257, 2007.
20. Chuang PT and McMahon AP: Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 397: 617-621, 1999.
21. Van den Heuvel M and Ingham PW: Smoothened encodes a receptor-like serpentine protein required for hedgehog signalling. Nature 382: 547-551, 1996.
22. Gallet A and Therond PP: Temporal modulation of the Hedgehog morphogen gradient by a Patched- dependent targeting to lysosomal compartment. Dev Biol 277: 51-62, 2005.
23. Varjosalo M, Björklund M, Cheng F, et al: Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 133: 537-548, 2008.
24. Taylor MD, Liu L, Raffel C, et al: Mutations in SUFU pre-dispose to medulloblastoma. Nat Genet 31: 306-310, 2002.
25. Kinzler KW, Bigner SH, Bigner DD, et al: Identification of an amplified, highly expressed gene in a human glioma. Science 236: 70-73, 1987.
26. Ruiz i Altaba A, Mas C and Stecca B: The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol 17: 438-447, 2007.
27. Bhatia N, Thiyagarajan S, Elcheva I, et al: Gli2 is targeted for ubiquitination and degradation by B-TrCP ubiquitin ligase. J Biol Chem 281: 19320-19326, 2006.
28. Tempé D, Casas M, Karaz S, et al: Multisite protein kinase A and glycogen synthase kinase 36 phosphorylation leads to Gli3 ubiquitination by SCF BTrCP. Mol Cell Biol 26: 4316-4326, 2006.
29. Hallikas O, Palin K, Sinjushina N, et al: Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 124: 47-59, 2006.
30. Kasper M, Schnidar H, Neill GW, et al: Selective modulation of Hedgehog/GLI target gene expression by EGF signaling in human keratinocytes. Mol Cell Biol 26: 6283-6299, 2006.
31. Katoh Y and Katoh M: WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med 17: 171-175, 2006.
32. Katoh Y and Katoh M: Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer. Int J Oncol 30: 751-755, 2007.
33. Katoh M and Katoh M: Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int J Mol Med 17: 681-685, 2006.
34. Katoh M and Katoh M: Conserved POU/OCT- and GATA-binding sites in 5pm-flanking promoter region of mammalian WNT8B orthologs. Int J Oncol 30: 1273-1277, 2007.
35. Katoh Y and Katch M: Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells. Int J Mol Med 20: 269-273, 2007.
36. Katoh M and Katoh M: Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer. Int J Oncol 31: 461-466, 2007.
37. Dennler S, André J, Alexaki I, et al: Induction of Sonic hedgehog mediators by TGF-β: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res 67: 6981-6986, 2007.
38. Katoh M and Katoh M: Crosstalk of WNT and FGF signaling pathways at GSK3β to regulate β-catenin and SNAIL signaling cascades. Cancer Biol Ther 5: 1059-1064, 2006.
39. Katoh M: Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 3: 30-38, 2007.
40. Bailey J, Singh PK and Hollingsworth MA: Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenetic proteins. J Cell Biochem 102: 829-839, 2007.
41. Katoh M: Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change, and genetic alteration in gastric cancer. Cancer Biol Ther 6: 832-839, 2007.
42. Wei CL, Wu Q, Vega VB, et al: A global map of p53 transcription-factor binding sites in the human genome. Cell 124: 207-219, 2006.
43. Lefort K, Mandinova A, Ostano P, et al: NOTCH1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinases. Genes Dev 21: 562-577, 2007.
44. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling. Science 284: 770-776, 1999.
45. Radtke F and Raj K: The role of Notch in tumorigenesis. Nat Rev Cancer 3: 765-767, 2003.
46. Katoh M and Katoh M: Notch signaling in gastrointestinal tract. Int J Oncol 30: 247-251, 2007.
47. Katoh M, Hirai M, Sugimura T and Terada M: Cloning and characterization of MST, a novel serine/threonine kinase with SH3 domain. Oncogene 10: 1447-1451, 1995.
48. Riobó NA, Lu K, Ai X, Haines GM and Emerson CP Jr: PI3K and Akt are essential for Sonic Hedgehog signaling. Proc Natl Acad Sci USA 103: 4505-4510, 2006.
49. Smeenk L, van Heeringen SJ, Koeppel M, et al: Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res (In press).
50. Shmueli A and Oren M: Mdm2: p53′s lifesaver? Mol Cell 25: 794-796, 2007.
51. Gwack Y, Sharma S, Nardone J, et al: A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441: 646-650, 2006.
52. Miller CT, Aggarwal S, Lin TK, et al: Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas. Cancer Res 63: 4136-4143, 2003.
53. Gorringe KL, Boussioutas A, Bowtell DD, et al: Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization. Genes Chromosomes Cancer 42: 247-259, 2005.
54. Momand J, Zambetti GP, Olson DC, George D and Levine AJ: The Mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245, 1992.
55. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992.
56. Shvarts A, Steegenga WT, Riteco N, et al: MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 15: 5349-5357, 1996.
57. Marine JC, Dyer MA and Jochemsen AG: MDMX: from bench to bedside. J Cell Sci 120: 371-378, 2007.
58. Günther T, Schneider-Stock R, Häckel C, et al: Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations. Mod Pathol 13: 621-626, 2000.
59. Riemenschneider MJ, Büschges R, Wolter M, et al: Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 59: 6091-6096, 1999.
60. Danovi D, Meulmeester E, Pasini D, et al: Amplification of MDMX (or MDM4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol 24: 5835-5843, 2004.
61. Laurie NA, Donovan SL, Shih CS, et al: Inactivation of the p53 pathway in retinoblastoma. Nature 444: 61-66, 2006.
62. Mayo LD and Donner DB: A PI3K/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98: 11598-11603, 2001.